Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$271.5K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| Mar 17 | QCOM | Qualcomm Inc/de | AGRANT | 2,563 | — | — | +21.3% | Open the original filing on SEC.gov |
| Mar 8 | QCOM | Qualcomm Inc/de | MEXER◆ | 2,355.2 | — | — | — | Open the original filing on SEC.gov |
| Mar 8 | QCOM | Qualcomm Inc/de | DTOISS | 759 | $135.69 | $103K | -5.9% | Open the original filing on SEC.gov |
| Mar 8 | QCOM | Qualcomm Inc/de | MEXER | 2,355 | — | — | +22.6% | Open the original filing on SEC.gov |
| Jan 27 | BDX | Becton Dickinson & Co | AGRANT | 1,098 | — | — | +13.7% | Open the original filing on SEC.gov |
| May 1, 2025 | HALO | Halozyme Therapeutics,… | AGRANT◆ | 5,750 | — | — | — | Open the original filing on SEC.gov |
| May 1, 2025 | HALO | Halozyme Therapeutics,… | AGRANT | 4,165 | — | — | +14.6% | Open the original filing on SEC.gov |
| Apr 28, 2025 | HALO | Halozyme Therapeutics,… | SSELL◷ | 200 | $61.00 | $12.2K | -0.7% | Open the original filing on SEC.gov |
| Apr 28, 2025 | HALO | Halozyme Therapeutics,… | SSELL◷ | 4,297 | $60.34 | $259.3K | -13.0% | Open the original filing on SEC.gov |